Fisher, Jeanine
McLaughlin, Fiona
Fawkes, Neil
Tipple, Hannah
Coyle, Cathal
Dettmar, Peter W. http://orcid.org/0000-0003-2931-5025
Funding for this research was provided by:
Reckitt Benckiser Pharmaceuticals
Article History
Accepted: 24 June 2021
First Online: 20 July 2021
Declarations
:
: The role of the study sponsor was to provide the experimental formulation of the infant liquid alginate product, review the data interpretation, and support the decision to submit the paper.
: FM, NF, HT, and CC are all employees of the study sponsor, Reckitt, who provided the new formulation of the infant liquid alginate product. PWD and JF received payment for writing and preparing the manuscript for publication.
: This is an in vitro study using an in vitro model. There were no patients or human tissue involved in this study and thus the requirement for ethical approval and informed consent were not applicable.
: Not applicable as an in vitro model was used and no human tissue or patients were involved.
: The following additional data will be made available on publication: the experimental data at each pH and the dose volume evaluated in the infant stomach model.
: Not applicable.
: All authors contributed to the study’s conception and design. Material preparation and data collection and analysis were performed by JF and PWD. The first draft of the manuscript was written by PWD, JF, and FM, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.